Table 4.

Regression Analyses—Total Medicare Reimbursements Per Phase ^a

	PRE phase			PERI phase			PERM phase
Cohort start year	1999	2000	2001	1999	2000	2001	1999	2000	2001
No. of observations	419 763	319 839	293 728	245 260	219 061	221 565	293 106	234 130	216 726
Age	−0.03	−0.03	−0.03	−0.03	−0.03	−0.03	−0.03	−0.03	−0.03
Black	0.24	0.21	0.21	0.34	0.30	0.30	0.53	0.49	0.45
Other race	0.18	0.17	0.18	0.18	0.18	0.16	0.31	0.32	0.30
Female	−0.04	−0.05	−0.06	0.05	0.07	0.08	0.03	0.05	0.04
Cancer	0.20	0.19	0.20	0.25	0.23	0.22	0.22	0.19	0.18
Congestive heart failure	0.25	0.26	0.27	0.49	0.46	0.47	0.45	0.43	0.42
Chronic obstructive pulmonary disease	0.22	0.23	0.21	0.44	0.40	0.40	0.43	0.42	0.39
Diabetes	0.13	0.12	0.11	0.24	0.23	0.24	0.29	0.30	0.27
Parkinson	0.07	0.06	0.04	0.27	0.24	0.23	0.19	0.20	0.17
Stroke	0.13	0.13	0.11	0.36	0.32	0.29	0.28	0.26	0.24

Abbreviations: PRE, pre–long-term care phase; PERI, peri–long term care phase; PERM, permanent long term care phase.

^aThe numbers in the cell are unstandardized β coefficient (on their original scales). All the coefficients are statistically significant at P < .01. The models also take account of state effects.